当前位置：药药网 / 药品研发 / 美国药品上市后承诺数据库
GARDASIL, Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant
申请企业
Merck Sharp & Dohme Corp.
药品名称
GARDASIL, Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant
承诺描述
Conduct an observational safety study in a U.S. Managed Care Organization (MCO) to assess the general short-term safety of the vaccine as it is administered to a larger male population 9 through 26 years of age.